NCT04507490

Brief Summary

Parkinson's disease has innumerous motor symptoms that impacting on the functional level of the patient, such as impairment in functional mobility and balance . Previous studies have already aimed to evaluate the effectiveness of whole body vibration, but without methodological criteria. The use of whole body vibration may be an alternative for the treatment of Parkinson's disease. Therefore, the objective of the study is to verify which frequency of vibration is able to improve the balance and mobility of patients with Parkinson's disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable parkinson-disease

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 11, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

August 15, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2020

Completed
Last Updated

August 11, 2020

Status Verified

August 1, 2020

Enrollment Period

2 months

First QC Date

August 5, 2020

Last Update Submit

August 7, 2020

Conditions

Keywords

Parkinson DiseaseBalanceFunction MobilityWhole body vibration

Outcome Measures

Primary Outcomes (4)

  • Change in Function mobility

    The evaluation of the functional mobility of individuals will be performed by the Timed Up and Go test. It will analyze the time spent by the individual to get up from a chair with arms, walk for three meters and return to the chair

    Before (T0) and immediate after vibration (T1)

  • Change in Static and dynamic balance

    The assessment of static and dynamic balance using the Biodex Balance System (BBS) tool, capable of evaluating the displacement of the center of mass in the anteroposterior and laterolateral axes on a circular platform that can oscillate up to 20 ° in all directions in the horizontal plane. Static balance was performed using the Postural Stability Test, while dynamic balance was assessed using the Limits of Stability Test. The MiniBest test was performed to assess dynamic balance. The test consists of the application of 14 tasks that measure the patient's dynamic balance in different positions, through 14 items, with scores ranging from zero to two

    Before (T0) and immediate after vibration (T1)

  • Change in static balance

    The indirect center of pressure (COP) was acquired by the baropodometric static platform (Sensor Medica). The patient was instructed to position himself on the platform with his arms relaxed along his body, in the usual posture and looking towards the horizon, with a postural adaptation time of 30 seconds. The collection started without being informed to the patient. The averages of the three acquisitions of the following measures were analyzed of center of pressure

    Before (T0) and immediate after vibration (T1)

  • Change in foot pressure

    The direct foot pressure was acquired by the baropodometric static platform (Sensor Medica).The patient was instructed to position himself on the platform with his arms relaxed along his body, in the usual posture and looking towards the horizon, with a postural adaptation time of 30 seconds. The collection started without being informed to the patient. The averages of the three acquisitions of the following measures were analyzed: (i) maximum pressure in the forefoot; (ii) maximum pressure in the midfoot and (iii) maximum pressure in the hindfoot.

    Before (T0) and immediate after vibration (T1)

Secondary Outcomes (5)

  • Change in Cadence of gait

    Before (T0) and immediate after vibration (T1)

  • Change in support phase of gait

    Before (T0) and immediate after vibration (T1)

  • Change in swing phase of gait

    Before (T0) and immediate after vibration (T1)

  • Change in Risk of falls

    Before (T0) and immediate after vibration (T1)

  • Change in Functionality assessment

    Before (T0) and immediate after vibration (T1)

Study Arms (3)

Whole body vibration 6 Hz

EXPERIMENTAL

application of whole body vibration in the following parameters:frequency 6 Hz, amplitude 4 mm, five cycles lasting 1 minutes and interval between cycles of 1 minute

Device: Whole body vibration

Whole body vibration 25 Hz

EXPERIMENTAL

application of whole body vibration in the following parameters: 25 Hz frequency, 4 mm amplitude, five cycles lasting 1 minute and interval between 1 minute cycles

Device: Whole body vibration

Whole body vibration sham

SHAM COMPARATOR

application of whole body vibration in the following parameters: The sham vibration will be performed with the platform disconnected. A sound device will be connected producing a noise similar to that of the connected platform for a time equivalent to that of the treatment protocol.

Device: Whole body vibration

Interventions

315/5000 application of whole body vibration with pre-established parameters for each group. All patients will participate in all groups, an interval of at least one week. They will be instructed to climb on the platform and to position a semi knee flexion and remain stationary during the vibration

Whole body vibration 25 HzWhole body vibration 6 HzWhole body vibration sham

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • · Minimum score of the Montreal Cognitive Assessment (MoCA) (27 points);
  • Regular antiparkinsonian pharmacological treatment;
  • Staged from I to III on the modified Hoehn \& Yahr scale.

You may not qualify if:

  • · Individuals with other neurological disorders, postural hypotension, vestibular, visual, cardiovascular or musculoskeletal disorders that affect the performance of the proposed tests;
  • other associated neurological disease
  • changes in medication in use for Parkinson's disease for at least sixty days before the start of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Luis Mendes

Paulista, Pernambuco, 53433-665, Brazil

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double blind. Only the interventionist will be allowed to access the vibration condition. In this way, the patient and the investigator will be blind for the type of vibration that the patient will receive.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: After confirming the eligibility criteria, patients will be asked to sign the informed consent form. Subsequently, they will be randomly allocated to three groups: (i) group 6 Hz: full body vibration (frequency 6 Hz, amplitude 4 mm, five cycles lasting 1 minutes and interval between cycles of 1 minute) , (ii) 25 Hz group: full body vibration (25 Hz frequency, 4 mm amplitude, five cycles lasting 1 minute and interval between 1 minute cycles) and (iii) sham group: The sham vibration will be performed with the platform disconnected. Additionally, a sound device will be connected producing a noise similar to that of the connected platform for a time equivalent to that of the treatment protocol. The patient will be instructed to position himself standing on the platform, with a semi knee flexion in order that the vibration wave does not propagate to the head. There will be a washout time of at least one week between one intervention and another
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Maria das Graças Rodrigues de Araújo

Study Record Dates

First Submitted

August 5, 2020

First Posted

August 11, 2020

Study Start

August 15, 2020

Primary Completion

October 15, 2020

Study Completion

November 15, 2020

Last Updated

August 11, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations